NKTCL has been associated with an inflamed phenotype, corresponding to the TSIM molecular subtype of the disease, and as recently shown, the presence of mutated PD-L1 is highly predictive of response to anti-PD-1 ICIs. The gene discussed is PDCD1; the disease is extranodal nasal NK/T cell lymphoma.